These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 20886180)
1. Prostanoid and TP-receptors in atherothrombosis: is there a role for their antagonism? Giannarelli C; Zafar MU; Badimon JJ Thromb Haemost; 2010 Nov; 104(5):949-54. PubMed ID: 20886180 [TBL] [Abstract][Full Text] [Related]
2. [Terutroban and endothelial TP receptors in atherogenesis]. Verbeuren TJ Med Sci (Paris); 2006 Apr; 22(4):437-43. PubMed ID: 16597416 [TBL] [Abstract][Full Text] [Related]
6. The thromboxane/endoperoxide receptor (TP): the common villain. Félétou M; Vanhoutte PM; Verbeuren TJ J Cardiovasc Pharmacol; 2010 Apr; 55(4):317-32. PubMed ID: 20422736 [TBL] [Abstract][Full Text] [Related]
7. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
8. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells. Shin Y; Romstedt KJ; Miller DD; Feller DR J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383 [TBL] [Abstract][Full Text] [Related]
9. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825 [TBL] [Abstract][Full Text] [Related]
10. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist. Hanasaki K; Arita H Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990 [TBL] [Abstract][Full Text] [Related]
11. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [TBL] [Abstract][Full Text] [Related]
12. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention. Chapman MJ Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Egan KM; Wang M; Fries S; Lucitt MB; Zukas AM; Puré E; Lawson JA; FitzGerald GA Circulation; 2005 Jan; 111(3):334-42. PubMed ID: 15655126 [TBL] [Abstract][Full Text] [Related]
17. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]